Welcome

NanGenex, member of the DRGT Group, is a Druggability Enabling High Throughput NanoActive™ Technology Platform Company. The company utilizes its integrated platform to provide breakthrough solutions to pharmaceutical, agrochemical and cosmetic companies in order to develop new generations of NanoActive products with significant performance benefits over conventional approaches.

The technology platform enables NanGenex to generate proprietary NanoActive™ materials by altering their physico-chemical properties to substantially improve their solubility, dissolution rate and bioavailability.

News

Latest Press Release

SAN FRANCISCO, CA, January 12, 2012
Druggability Technologies Announces Financial Investment by SPCH

Druggability Technologies Holdings Limited (DRGT), a privately held biotechnology platform company, announced today that it has completed an initial round of financing totaling $4,000,000.

Read more		  

Upcoming event

 

March 1-2, 2012, Krems, Austria 
BioNanoMed 2012